PCN6 A COST-EFFECTIVENESS ANALYSIS OF ADJUVANT THERAPY WITH EXEMESTANE, ANASTROZOLE, LETROZOLE OR TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH EARLYSTAGE BREAST CANCER IN MEXICO
Abstract
Authors
J Mould-Quevedo J Tapia-Valencia G Davila-Loaiza